LigaChem Biosciences has dosed the first patient in a global phase 1/2 trial of LCB02A, its experimental antibody-drug ...

Mold-covered walls, cockroach-infested rooms and patients with limited mobility who cannot even contemplate visiting a ...

Vaxcellbio's experimental natural killer (NK) cell therapy, VCB-1102, combined with hepatic arterial infusion chemotherapy ...

Only 19.3 percent of patients referred from tertiary general hospitals were confirmed to have received follow-up care at ...

Sky Labs said Friday that more patients reached their target blood pressure (BP) when doctors adjusted medication using its ...

AriBio said Friday it will release topline results from its global phase 3 trial of oral Alzheimer’s disease drug candidate ...

SEERS has received ethics approval in Abu Dhabi to begin a pilot of its AI-based arrhythmia screening service, a final step ...

Nearly 30,000 people in Korea have type 1 diabetes, with adults accounting for more than 70 percent of newly diagnosed cases, ...

AI in clinical trials is moving beyond routine task automation toward integrated platforms that connect workflows, improve ...

Urologists have called for measures to narrow regional disparities in prostate cancer diagnosis and improve reimbursement for ...

The Ministry of Food and Drug Safety (MFDS) said Thursday it had approved Jascayd (nerandomilast), a treatment for idiopathic ...

Recurrent ischemic strokes in patients with cervicocephalic artery dissection occur predominantly within the first week after ...